Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Balancing access to BPaLM regimens and risk of resistance.
Van Rie A, Walker T, de Jong B, Rupasinghe P, Rivière E, Dartois V, Sonnenkalb L, Machado D, Gagneux S, Supply P, Dreyer V, Niemann S, Goig G, Meehan C, Tagliani E, Cirillo DM. Van Rie A, et al. Among authors: tagliani e. Lancet Infect Dis. 2022 Oct;22(10):1411-1412. doi: 10.1016/S1473-3099(22)00543-6. Epub 2022 Aug 22. Lancet Infect Dis. 2022. PMID: 36007529 No abstract available.
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM. Tagliani E, et al. J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15. J Clin Microbiol. 2015. PMID: 26179309 Free PMC article.
Reaching consensus on drug resistance conferring mutations.
Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium. Cirillo DM, et al. Among authors: tagliani e. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S31-S32. doi: 10.1016/j.ijmyco.2016.09.062. Epub 2016 Nov 15. Int J Mycobacteriol. 2016. PMID: 28043595 Free article.
Reaching consensus on drug resistance conferring mutations.
Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium. Cirillo DM, et al. Among authors: tagliani e. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S33. doi: 10.1016/j.ijmyco.2016.11.009. Epub 2016 Nov 25. Int J Mycobacteriol. 2016. PMID: 28043596 Free article. No abstract available.
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC. Miotto P, et al. Among authors: tagliani e. Eur Respir J. 2017 Dec 28;50(6):1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284687 Free PMC article.
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.
Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium. Walker TM, et al. Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Lancet Infect Dis. 2018. PMID: 29326013 Free PMC article.
40 results